{
    "organizations": [],
    "uuid": "01491c9c171048c5dbd16e1f821628f2cc0c3bdc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-genocea-biosciences-announces-prop/brief-genocea-biosciences-announces-proposed-concurrent-public-offerings-of-common-stock-idUSASB0C14B",
    "ord_in_thread": 0,
    "title": "BRIEF-Genocea Biosciences Announces Proposed Concurrent Public Offerings Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Genocea Biosciences Inc:\n* GENOCEA BIOSCIENCES, INC. ANNOUNCES PROPOSED CONCURRENT PUBLIC OFFERINGS OF COMMON STOCK AND CLASS A WARRANTS AND SERIES A CONVERTIBLE PREFERRED STOCK AND CLASS A WARRANTS\n* GENOCEA BIOSCIENCES INC - ‍GENOCEA INTENDS TO USE NET PROCEEDS FROM CONCURRENT OFFERINGS TO SUPPORT ONGOING DEVELOPMENT OF ITS GEN-009 PROGRAM​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T05:51:00.000+02:00",
    "crawled": "2018-01-17T20:17:25.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "genocea",
        "bioscience",
        "inc",
        "genocea",
        "bioscience",
        "announces",
        "proposed",
        "concurrent",
        "public",
        "offering",
        "common",
        "stock",
        "class",
        "warrant",
        "series",
        "convertible",
        "preferred",
        "stock",
        "class",
        "warrant",
        "genocea",
        "bioscience",
        "inc",
        "intends",
        "use",
        "net",
        "proceeds",
        "concurrent",
        "offering",
        "support",
        "ongoing",
        "development",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}